Macrolide Resistance and Longer-Term Assessment of Azithromycin in MORDOR I

Affiliations

Comment

Dimitri Poddighe. N Engl J Med. 2019.

. 2019 Nov 28;381(22):2184.

doi: 10.1056/NEJMc1910014.

¹ Nazarbayev University School of Medicine, Nur-Sultan City, Kazakhstan dimitri.poddighe@nu.edu.kz.

No abstract available

Comment in

Macrolide Resistance and Longer-Term Assessment of Azithromycin in MORDOR I. Reply.
Lietman TM, Doan T, Keenan JD. Lietman TM, et al. N Engl J Med. 2019 Nov 28;381(22):2184-2185. doi: 10.1056/NEJMc1910014. N Engl J Med. 2019. PMID: 31774979 No abstract available.

Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
Keenan JD, Arzika AM, Maliki R, Boubacar N, Elh Adamou S, Moussa Ali M, Cook C, Lebas E, Lin Y, Ray KJ, O'Brien KS, Doan T, Oldenburg CE, Callahan EK, Emerson PM, Porco TC, Lietman TM. Keenan JD, et al. N Engl J Med. 2019 Jun 6;380(23):2207-2214. doi: 10.1056/NEJMoa1817213. N Engl J Med. 2019. PMID: 31167050 Free PMC article.
Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.
Doan T, Arzika AM, Hinterwirth A, Maliki R, Zhong L, Cummings S, Sarkar S, Chen C, Porco TC, Keenan JD, Lietman TM; MORDOR Study Group. Doan T, et al. N Engl J Med. 2019 Jun 6;380(23):2271-2273. doi: 10.1056/NEJMc1901535. N Engl J Med. 2019. PMID: 31167060 Free PMC article. No abstract available.